Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Quantitative podocyte parameters predict human native kidney and allograft half-lives
Abhijit S. Naik, … , Yi Li, Roger C. Wiggins
Abhijit S. Naik, … , Yi Li, Roger C. Wiggins
Published May 19, 2016
Citation Information: JCI Insight. 2016;1(7):e86943. https://doi.org/10.1172/jci.insight.86943.
View: Text | PDF
Clinical Medicine Aging Nephrology

Quantitative podocyte parameters predict human native kidney and allograft half-lives

  • Text
  • PDF
Abstract

BACKGROUND. Kidney function decreases with age. A potential mechanistic explanation for kidney and allograft half-life has evolved through the realization that linear reduction in glomerular podocyte density could drive progressive glomerulosclerosis to impact both native kidney and allograft half-lives.

METHODS. Predictions from podometrics (quantitation of podocyte parameters) were tested using independent pathologic, functional, and outcome data for native kidneys and allografts derived from published reports and large registries.

RESULTS. With age, native kidneys exponentially develop glomerulosclerosis, reduced renal function, and end-stage kidney disease, projecting a finite average kidney life span. The slope of allograft failure rate versus age parallels that of reduction in podocyte density versus age. Quantitative modeling projects allograft half-life at any donor age, and rate of podocyte detachment parallels the observed allograft loss rate.

CONCLUSION. Native kidneys are designed to have a limited average life span of about 100–140 years. Allografts undergo an accelerated aging-like process that accounts for their unexpectedly short half-life (about 15 years), the observation that older donor age is associated with shorter allograft half-life, and the fact that long-term allograft survival has not substantially improved. Podometrics provides potential readouts for these processes, thereby offering new approaches for monitoring and intervention.

FUNDING: National Institutes of Health.

Authors

Abhijit S. Naik, Farsad Afshinnia, Diane Cibrik, Jeffrey B. Hodgin, Fan Wu, Min Zhang, Masao Kikuchi, Larysa Wickman, Milagros Samaniego, Markus Bitzer, Jocelyn E. Wiggins, Akinlolu Ojo, Yi Li, Roger C. Wiggins

×

Figure 3

Native kidney half-life estimations.

Options: View larger image (or click on image) Download as PowerPoint
Native kidney half-life estimations.
(A and B) Proportion of glomeruli w...
(A and B) Proportion of glomeruli with global glomerulosclerosis derived from Kaplan et al. (21). Meaned data for global glomerulosclerosis prevalence appears to increase exponentially with age. The dotted line is extended to determine the age at which 95% of glomeruli are projected to be sclerotic (presumed to be incident end-stage kidney disease [ESKD]), as shown by the dashed lines with arrows. This projected value is 116 years. (C and D) Estimated glomerular filtration rate (eGFR) projections from the NHANES dataset. eGFR was calculated as the creatinine (Creat) clearance per 1.73 m2. (C) Reduction in eGFR with age of all subjects (black bars) and only those subjects without diabetes or hypertension (gray bars). (D) The rate of decrease in eGFR accelerates with age such that the age at which eGRF is projected to reach 5 ml/min per 1.73 m2 (presumed to be ESKD) for all subjects is about 107 years and for only those without diabetes or hypertension is about 110 years, as shown by the dotted lines with arrows. See supplemental material for details of fitting a quadratic polynomial equation and the derived mean projected age and ranges at ESKD. (E and F) Reported incident treated ESKD from the USRDS Annual Data Report (24). The number of incident aggregated treated ESKD per million of population is shown in E, demonstrating an exponential increase with age. (F) Cumulative reported treated ESKD as percentage of the population plotted on a log scale in order to estimate the age at which 50% of the population would be projected to reach ESKD (i.e., the half-life of native kidneys), as shown by the arrows. The projected value is 140 years. The r2 values shown are for aggregated data.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts